Wedbush Sees Tesla Merging with $1.25T SpaceX-xAI Entity in 12-18 Months

TSLATSLA

Wedbush’s Dan Ives highlights Tesla’s $2 billion xAI investment and forecasts “cross-pollination” with SpaceX following its $1.25 trillion merger with xAI. He predicts a potential tie-up of Tesla, SpaceX and xAI within 12–18 months to build an AI and robotics juggernaut.

1. Analyst Remains Bearish on Tesla Despite Strategic Initiatives

Despite Tesla’s ambitious Robotaxi ride-sharing service and Optimus humanoid robot programs scheduled for significant progress in 2026, Wedbush analyst Daniel Sparks maintains a bearish stance on the stock. He highlights a 9% decline in global vehicle deliveries in 2025 and a 46% slump in annual net income, underscoring near-term operational headwinds. Even though management plans to more than double annual capital expenditures to over $20 billion and accelerate development of autonomous and robotics businesses, Sparks argues these investments may not translate into profit growth quickly enough to justify current expectations.

2. Valuation Stretched Relative to Fundamentals

Tesla trades at an approximate price-to-earnings ratio of 368, with a market capitalization exceeding $1.5 trillion—levels that, according to Sparks, already reflect full credit for future success in both electric vehicles and emerging ventures. He contends that these valuation multiples leave little margin of safety for investors, especially given cyclical risks in the automotive market and intensifying competition from established automakers and Chinese EV manufacturers.

3. Mixed Wall Street Outlook on Long-Term Growth Drivers

While some analysts forecast Tesla’s valuation could exceed $2 trillion by the end of 2026, citing an evolving AI ecosystem and potential integrations with Musk’s other ventures, others caution that the company’s deliberate downsizing of its core electric vehicle division introduces uncertainty. Morgan Stanley and Wolfe Research have identified a “catalyst-rich year ahead” for autonomous driving and robotics, yet stress that market size, regulatory approvals and consumer adoption timelines remain highly uncertain, resulting in a split among institutional investors between cautious optimism and outright skepticism.

Sources

FRRFS
+15 more